Abstract
Novel furoxan-based nitric oxide (NO)-releasing DDB derivatives (7a-j) were synthesized. Compounds 7i and 7j significantly reversed the resistance of MCF-7/Adr cells to doxorubicin in the combination treatment, and markedly increased the intracellular accumulation of doxorubicin probably via inhibiting Pgp-mediated intracellular drug efflux as well as down-regulating doxorubicin-induced Pgp expression. It was demonstrated that NO released by 7i and 7j played an important role in increasing intracellular doxorubicin accumulation and chemo-sensitizing MCF-7/Adr cells to doxorubicin, and the synergic effects of DDB and NO-donor moieties in 7i and 7j may contribute to reversing Pgp-mediated MDR in MCF-7/Adr cells to doxorubicin.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
-
Evaluation Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism*
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Biphenyl Compounds / chemical synthesis
-
Biphenyl Compounds / chemistry
-
Biphenyl Compounds / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Dicarboxylic Acids / chemical synthesis
-
Dicarboxylic Acids / chemistry
-
Dicarboxylic Acids / pharmacology*
-
Doxorubicin / chemistry
-
Doxorubicin / pharmacology
-
Drug Resistance, Multiple / drug effects*
-
Drug Resistance, Neoplasm / drug effects*
-
Drug Screening Assays, Antitumor
-
Humans
-
Molecular Structure
-
Nitric Oxide / chemistry*
Substances
-
ATP Binding Cassette Transporter, Subfamily B, Member 1
-
Antineoplastic Agents
-
Biphenyl Compounds
-
Dicarboxylic Acids
-
dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylene dioxybiphenyl-2,2'-dicarboxylate
-
Nitric Oxide
-
Doxorubicin